Proton pump inhibitor maintenance therapy in the prevention of recurrent duodenal ulcer

Chinese Journal of Gastroenterology

Volumn 6, Issue 1, 2001, Pages 43-45

  Zhou, L ^a   Dong, X ^a   Cheng, H ^a   Huang, X ^a   Zhu, Y ^a   Lu, Y ^a   Ding, S ^a   Xia, Z ^a   Gu, F ^a   Yang, X ^a   Jin, Z ^a   Lin, S ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Duodenal ulcer; Follow up studies; Proton pump antagonists inhibitors; Recurrence prevention control

Indexed keywords

HEXOSAMINE; LANSOPRAZOLE; PEPSIN A; PROTON PUMP INHIBITOR;

ACIDITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUODENUM ULCER; ENZYME ACTIVITY; ENZYME ASSAY; GASTROSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PH; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; SCAR; SMOKING; STOMACH ACID SECRETION; STOMACH JUICE; STOMACH MUCOSA; STOMACH PH; SYMPTOM; TIME;

EID: 0035036249     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Efficacy and safety of long-term maintenance therapy of duodenal ulcers
2. Antacid maintenance therapy in the prevention of duodenal ulcer relapse
3. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial
4. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: Prospective nonrandomized trial on 125 patients
5. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years
6. "Reappearance" of Helicobacter pylori after eradication: Implications on duodenal ulcer recurrence: A prospective 6 year study
7. Cure of duodenal ulcer associated with eradication of Helicobacter pylori
8. The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer